Xiao-Ya Lou

473 total citations
13 papers, 388 citations indexed

About

Xiao-Ya Lou is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Xiao-Ya Lou has authored 13 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Xiao-Ya Lou's work include Pharmacogenetics and Drug Metabolism (4 papers), MicroRNA in disease regulation (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Xiao-Ya Lou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), MicroRNA in disease regulation (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Xiao-Ya Lou collaborates with scholars based in China and United States. Xiao-Ya Lou's co-authors include Meihua Bao, Hong‐Hao Zhou, Yu Cheng, Feng Xing, Yiwen Zhang, Yiwen Zhang, Yu Cheng, Yu Jing, Qiang Qu and Min Zhan and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and European Journal of Clinical Pharmacology.

In The Last Decade

Xiao-Ya Lou

13 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao-Ya Lou China 9 248 183 44 37 36 13 388
Meng‐yuan Zhou China 12 255 1.0× 160 0.9× 58 1.3× 24 0.6× 38 1.1× 26 383
Wenyi Deng China 10 176 0.7× 122 0.7× 64 1.5× 39 1.1× 41 1.1× 13 315
Nianxin Jiang China 8 253 1.0× 138 0.8× 33 0.8× 42 1.1× 45 1.3× 15 405
Wu‐Hsien Kuo Taiwan 9 224 0.9× 99 0.5× 31 0.7× 75 2.0× 32 0.9× 12 362
Manal L. Louka Egypt 12 173 0.7× 119 0.7× 35 0.8× 45 1.2× 33 0.9× 26 359
Yameng Cui China 12 490 2.0× 322 1.8× 63 1.4× 39 1.1× 69 1.9× 16 630
Lingyan Yuan China 10 257 1.0× 142 0.8× 36 0.8× 24 0.6× 107 3.0× 15 368
Rui Yan China 11 224 0.9× 104 0.6× 45 1.0× 38 1.0× 37 1.0× 36 446
Xiaoming Lin China 11 312 1.3× 181 1.0× 39 0.9× 42 1.1× 12 0.3× 35 453
Ranchen Xu China 6 351 1.4× 179 1.0× 85 1.9× 23 0.6× 34 0.9× 7 463

Countries citing papers authored by Xiao-Ya Lou

Since Specialization
Citations

This map shows the geographic impact of Xiao-Ya Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Ya Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Ya Lou more than expected).

Fields of papers citing papers by Xiao-Ya Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Ya Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Ya Lou. The network helps show where Xiao-Ya Lou may publish in the future.

Co-authorship network of co-authors of Xiao-Ya Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Ya Lou. A scholar is included among the top collaborators of Xiao-Ya Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Ya Lou. Xiao-Ya Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lin, Huiting, Xiao-Ya Lou, Yiming Wang, et al.. (2024). Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?. The Breast. 74. 103680–103680. 1 indexed citations
2.
Guo, Dong, et al.. (2022). A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients. European Journal of Clinical Pharmacology. 78(4). 565–578. 1 indexed citations
3.
Bao, Meihua, et al.. (2018). Effects of Oridonin on Hepatic Cytochrome P450 Expression and Activities in PXR-Humanized Mice. Biological and Pharmaceutical Bulletin. 41(5). 707–712. 53 indexed citations
4.
Sun, Hong, Xiao-Ya Lou, Xiaoying Wu, et al.. (2016). Up-Regulation of CYP2C19 Expression by BuChang NaoXinTong via PXR Activation in HepG2 Cells. PLoS ONE. 11(7). e0160285–e0160285. 9 indexed citations
5.
Qin, Chong-Zhen, Xiao-Ya Lou, Qiao‐Li Lv, et al.. (2015). MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation.. PubMed. 70(10). 668–73. 22 indexed citations
6.
Lou, Xiao-Ya, Chong-Zhen Qin, Meihua Bao, et al.. (2015). Analysis of Niemann-Pick C1-like 1 (NPC1L1) genetic polymorphisms and haplotypes in Chinese Han population.. PubMed. 70(9). 581–5. 2 indexed citations
7.
Sun, Hong, Qiang Qu, Jian Qu, et al.. (2015). URAT1Gene Polymorphisms Influence Uricosuric Action of Losartan in Hypertensive Patients with Hyperuricemia. Pharmacogenomics. 16(8). 855–863. 8 indexed citations
8.
Bao, Meihua, Yiwen Zhang, Xiao-Ya Lou, Yu Cheng, & Hong‐Hao Zhou. (2014). Protective Effects of Let-7a and Let-7b on Oxidized Low-Density Lipoprotein Induced Endothelial Cell Injuries. PLoS ONE. 9(9). e106540–e106540. 60 indexed citations
9.
Lou, Xiao-Ya, Wei Zhang, Wang Guo, et al.. (2014). The effect of Na+/taurocholate cotransporting polypeptide (NTCP) c.800C > T polymorphism on rosuvastatin pharmacokinetics in Chinese healthy males.. PubMed. 69(10). 775–9. 12 indexed citations
10.
Bao, Meihua, et al.. (2014). Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS. Canadian Journal of Physiology and Pharmacology. 92(4). 299–306. 18 indexed citations
11.
Bao, Meihua, Feng Xing, Yiwen Zhang, et al.. (2013). Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem Cells. International Journal of Molecular Sciences. 14(11). 23086–23102. 165 indexed citations
12.
Zhan, Min, Qiang Qu, Guo Wang, et al.. (2013). Let-7c Inhibits NSCLC Cell Proliferation by Targeting HOXA1. Asian Pacific Journal of Cancer Prevention. 14(1). 387–392. 17 indexed citations
13.
Qu, Qiang, Jian Qu, Min Zhan, et al.. (2013). Different Involvement of Promoter Methylation in the Expression of Organic Cation/Carnitine Transporter 2 (OCTN2) in Cancer Cell Lines. PLoS ONE. 8(10). e76474–e76474. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026